Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
1154 results:
1. Impact of Postoperative Chemotherapy on Survival in Patients with Primary Central Nervous System lymphoma: A Study Based on the SEER Database.
Chen Y; Zheng S; Zheng S; Lin H; Wei L; Chen S
Br J Hosp Med (Lond); 2024 Sep; 85(9):1-22. PubMed ID: 39347676
[No Abstract] [Full Text] [Related]
2. Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and lymphoma: A Population-Based Descriptive Study.
Agarwal A; Kekre N; Atkins H; Imsirovic H; Hutton B; Coyle D; Thavorn K
Curr Oncol; 2024 Jul; 31(8):4192-4208. PubMed ID: 39195296
[TBL] [Abstract] [Full Text] [Related]
3. Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-hodgkin lymphoma: a phase I/II trial.
Wang L; Fang C; Kang Q; Huang W; Chen Z; Zhao W; Wang L; Wang Y; Tan K; Guo X; Xu Y; Wang S; Wang L; Qiao J; Tang Z; Yu C; Xu Y; Li Y; Yu L
Blood Cancer J; 2024 Aug; 14(1):130. PubMed ID: 39112452
[TBL] [Abstract] [Full Text] [Related]
4. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents.
Kaur C; Thakur A; Liou KC; Rao NV; Nepali K
Expert Opin Investig Drugs; 2024 Sep; 33(9):897-914. PubMed ID: 39096234
[TBL] [Abstract] [Full Text] [Related]
5. Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies.
Olejarz W; Sadowski K; Szulczyk D; Basak G
Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062986
[TBL] [Abstract] [Full Text] [Related]
6. hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, phl-C1, and phl-C2 report from the COG and EuroNet-phl.
Pabari R; McCarten K; Flerlage J; Lai H; Mauz-Körholz C; Dieckmann K; Palese M; Kaste S; Castellino SM; Kelly KM; Stoevesandt D; Kurch L
Blood Adv; 2024 Sep; 8(18):4856-4865. PubMed ID: 39058968
[TBL] [Abstract] [Full Text] [Related]
7. hodgkin lymphoma: hypodense lesions in mediastinal masses.
Damek A; Kurch L; Franke FC; Attarbaschi A; Beishuizen A; Cepelova M; Ceppi F; Daw S; Dieckmann K; Fernández-Teijeiro A; Feuchtinger T; Flerlage JE; Fosså A; Georgi TW; Hasenclever D; Hraskova A; Karlen J; Klekawka T; Kluge R; Körholz D; Landman-Parker J; Leblanc T; Mauz-Körholz C; Metzler M; Pears J; Steglich J; Uyttebroeck A; Vordermark D; Wallace WH; Wohlgemuth WA; Stoevesandt D
Sci Rep; 2024 Jun; 14(1):14591. PubMed ID: 38918503
[TBL] [Abstract] [Full Text] [Related]
8. Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.
Wu JH; Pennesi E; Bautista F; Garrett M; Fukuhara K; Brivio E; Ammerlaan ACJ; Locatelli F; van der Sluis IM; Rossig C; Chen-Santel C; Bielorai B; Petit A; Starý J; Díaz-de-Heredia C; Rives S; O'Marcaigh A; Rizzari C; Engstler G; Nysom K; Rubio-San-Simón A; Bruno B; Bertrand Y; Brethon B; Rialland F; Plat G; Dirksen U; Sramkova L; Zwaan CM; Huitema ADR
Clin Pharmacokinet; 2024 Jul; 63(7):981-997. PubMed ID: 38907948
[TBL] [Abstract] [Full Text] [Related]
9. Association between Epstein-Barr virus LMP-1 and hodgkin lymphoma LMP-1 mechanisms in hodgkin lymphoma development.
Oliveira LOD; Costa IB; Quaresma JAS
Rev Med Virol; 2024 Jul; 34(4):e2561. PubMed ID: 38877989
[TBL] [Abstract] [Full Text] [Related]
10. Diffuse large B-cell lymphoma with central nervous system symptoms during the maintenance therapy of acute lymphoblastic leukemia: a case report and literature review.
Wang LL; Liu X; Tang X; Wen F; Liu S; Mai H
Chin Clin Oncol; 2024 Aug; 13(4):57. PubMed ID: 38859607
[TBL] [Abstract] [Full Text] [Related]
11. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies.
Al Hadidi S; Heslop HE; Brenner MK; Suzuki M
Mol Ther; 2024 Aug; 32(8):2444-2460. PubMed ID: 38822527
[TBL] [Abstract] [Full Text] [Related]
12. The impact of treatment for childhood classical hodgkin lymphoma according to the EuroNet-phl-C2 protocol on serum anti-Müllerian Hormone.
Drechsel KCE; Broer SL; Stoutjesdijk FS; van Dulmen-den Broeder E; Beishuizen A; Wallace WH; Körholz D; Mauz-Körholz C; Hasenclever D; Cepelova M; Uyttebroeck A; Ronceray L; Twisk JWR; Kaspers GJL; Veening MA
Hum Reprod; 2024 Aug; 39(8):1701-1711. PubMed ID: 38794915
[TBL] [Abstract] [Full Text] [Related]
13. Investigating the safety and feasibility of osteopathic manipulative medicine in hospitalized children and adolescent young adults with cancer.
Belsky JA; Brown AM
J Osteopath Med; 2024 Sep; 124(9):399-406. PubMed ID: 38669608
[TBL] [Abstract] [Full Text] [Related]
14. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
15. Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study.
Aldoss I; Zhang J; Robbins M; Song J; Al Malki MM; Otoukesh S; Sandhu K; Agrawal V; Herrera AF; Popplewell LL; Ghoda L; Stein A; Marcucci G; Forman S; Pullarkat V
Leuk Lymphoma; 2024 Aug; 65(8):1127-1135. PubMed ID: 38629176
[TBL] [Abstract] [Full Text] [Related]
16. Update on FDG-PET in pediatric lymphoma.
Kurch L; Kluge R
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
[TBL] [Abstract] [Full Text] [Related]
17. Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-hodgkin lymphoma in a US population-based dataset.
Little MP; Mai JZ; Fang M; Chernyavskiy P; Kennerley V; Cahoon EK; Cockburn MG; Kendall GM; Kimlin MG
Br J Cancer; 2024 May; 130(9):1441-1452. PubMed ID: 38424165
[TBL] [Abstract] [Full Text] [Related]
18. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
Gaietto A; Panetta JC; Pauley JL; Relling MV; Ribeiro R; Ehrhardt MJ; Pui CH; Inaba H; Swanson HD
Cancer Chemother Pharmacol; 2024 Jun; 93(6):617-625. PubMed ID: 38416167
[TBL] [Abstract] [Full Text] [Related]
19. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
Shendy K; Abdelkawy K; Ali AA; Belal F; Abdelhakiem M; Magdy G; Anber N; Elbarbry F
Xenobiotica; 2024 Feb; 54(2):95-105. PubMed ID: 38381003
[TBL] [Abstract] [Full Text] [Related]
20. Treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia.
Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim TM; Yoon SS; Park H; Kim I
Medicine (Baltimore); 2024 Feb; 103(7):e37100. PubMed ID: 38363899
[TBL] [Abstract] [Full Text] [Related]
[Next]
